Skip to main content
Premium Trial:

Request an Annual Quote

Roche Gets FDA OK for New Hepatitis C Test

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche today said that it has received US Food and Drug Administration clearance for the second-generation version its real-time PCR Cobas TaqMan HCV Test.

The test quantifies the amount of hepatitis C viral RNA in human plasma or serum of HCV-infected individuals. It incorporates a manual specimen preparation with Roche's Cobas TaqMan 48 Analyzer for automated amplification and detection.

Teresa Wright, chief medical officer of Roche Molecular Diagnostics, said in a statement that the test "is key to measuring the effectiveness of many antivirals that are currently in clinical development for the treatment of hepatitis C."

Last month, the FDA cleared for marketing Roche's second-generation Cobas AmpliPrep/Cobas TaqMan HBV Test for quantitative detection of hepatitis B virus DNA in human plasma or serum for patients on hepatitis B virus antiviral therapy.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.